Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver diamine fluoride for arresting dental caries in primary school children
IRCT20240205060915N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of silver diamine fluoride in carious lesion and early childhood caries (ECC) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Effectiveness of 38% silver diamine fluoride in arresting dental caries lesions and Cost-effectiveness of 38% silver diamine fluoride. Started Feb 2024; status: completed.
02
Drugs
silver diamine fluoride
03
Conditions
carious lesionearly childhood caries (ECC)
Beyond the preview
Go deeper on IRCT20240205060915N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240205060915N1.